Company / Shareholders' Equity
Merck & Co. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$52.6B
FY2025
5-year range
$37.6B / $52.6B
FY2021-FY2025
Trend
+13.6%
vs FY2024
Sector context
#3 of 213
Health Care
What the data says
Among 213 Health Care companies, Merck & Co. is in the top 1% for shareholders' equity. Shareholders' Equity has fluctuated over the past 10 years, ranging from $25.3B in FY2020 to $52.6B in FY2025.
Based on SEC 10-K filings.
$52.6B in FY2025 with a 5-year CAGR of +15.8%. Ranks 3rd among 213 companies in Health Care.
Improved from $37.6B to $52.6B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
+1963.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 13.6% year-over-year.
- Ranks #3 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2020.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $52.6B | +13.6% |
| FY2024 | $46.3B | +23.2% |
| FY2023 | $37.6B | -18.3% |
| FY2022 | $46.0B | +20.4% |
| FY2021 | $38.2B | +50.8% |
| FY2020 | $25.3B | -2.3% |
| FY2019 | $25.9B | -3.0% |
| FY2018 | $26.7B | -22.2% |
| FY2017 | $34.3B | -14.3% |
| FY2016 | $40.1B | -10.3% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026